Emeritus Research

Melbourne, Australia Specialty Founded 2010 11-50 employees

Melbourne-based CRO specializing in Phase I-IIa first-in-human studies, offering rapid trial startup under Australia's CTN scheme with access to leading Australian clinical pharmacology units.